Authors/Disclosures
|
Scott McGinnis, MD
(Brigham and Women'S Hospital)
|
Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. |
|
Hyemi Chong
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Duygu Selcen, MD, FAAN
(Mayo Clinic)
|
Dr. Selcen has nothing to disclose. |
|
David A. Wolk, MD, FAAN
(University of Pennsylvania)
|
Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly. |
|
Kirk R. Daffner, MD, FAAN
(Brigham & Women's Hospital - Harvard Medical School)
|
The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM. |